Baishen Zhang

3PUBLICATIONS
3CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 07, 2024
Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis.

Baishen Zhang, Jing Chen, Hui Yu

|Apr 12, 2024
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study.

Baishen Zhang, Yao Liu, Zhiting Chen

|Mar 25, 2024
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer.

Baishen Zhang, Jing Chen, Hui Yu

Pageof 1

Frequent Collaborators

2 joint publications

Likun Chen

1 joint publications

Hui Yu

1 joint publications

Chao Cheng